Adam G. Stewart

Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing <i>Enterobacter</i> spp, <i>Citrobacter freundii</i>, <i>Morganella morganii</i>, <i>Providencia</i> spp, or <i>Serratia marcescens</i>: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Adam G. Stewart, David L. Paterson, Barnaby Edward Young et al. · Open Forum Infectious Diseases · 2021 · 85 citations · Full text

An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and <i>Pseudomonas aeruginosa</i>

Burcu Isler, Patrick N. A. Harris, Adam G. Stewart et al. · Journal of Antimicrobial Chemotherapy · 2020 · 53 citations

New Cefepime/bli Combinations, Pharmacotherapy, Antimicrobial Chemotherapy +22

Morganella morganii, an Emerging Cause of Bloodstream Infections

Kevin B. Laupland, David L. Paterson, Felicity Edwards et al. · Microbiology Spectrum · 2022 · 40 citations · Full text

How urgent is the need for new antifungals?

Adam G. Stewart, David L. Paterson · Expert Opinion on Pharmacotherapy · 2021 · 35 citations

Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections

Adam G. Stewart, Patrick N. A. Harris, Andrew Henderson et al. · Journal of Antimicrobial Chemotherapy · 2020 · 31 citations